BCR-ABL1-induced leukemogenesis and autophagic targeting by arsenic trioxide.

Goussetis, Dennis J

BCR-ABL1-induced leukemogenesis and autophagic targeting by arsenic trioxide. [electronic resource] - Autophagy Jan 2013 - 93-4 p. digital

Publication Type: Journal Article

1554-8635

10.4161/auto.22259 doi


Antineoplastic Agents--pharmacology
Arsenic Trioxide
Arsenicals
Autophagy--drug effects
Fusion Proteins, bcr-abl--metabolism
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy
Models, Biological
Neoplastic Stem Cells--drug effects
Oxides--toxicity
Translational Research, Biomedical